|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
NL8300698A
(nl)
|
1983-02-24 |
1984-09-17 |
Univ Leiden |
Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
DK122686D0
(da)
|
1986-03-17 |
1986-03-17 |
Novo Industri As |
Fremstilling af proteiner
|
|
FR2613624B1
(fr)
|
1987-04-10 |
1990-11-23 |
Roussy Inst Gustave |
Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
CA1333564C
(en)
|
1988-08-02 |
1994-12-20 |
Thomas Julius Borody |
Treatment of gastro-intestinal disorders
|
|
KR100225087B1
(ko)
|
1990-03-23 |
1999-10-15 |
한스 발터라벤 |
피타아제의 식물내 발현
|
|
DK0531372T4
(da)
|
1990-05-09 |
2004-08-09 |
Novozymes As |
Cellulasepræparat omfattende et endoglucanaseenzym
|
|
GB9107305D0
(en)
*
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
|
US5443951A
(en)
|
1992-07-20 |
1995-08-22 |
Kabushiki Kaisha Yakult Honsha |
Species-specific oligonucleotides for bifidobacteria and a method of detection using the same
|
|
EP0673429B1
(en)
|
1992-12-10 |
2002-06-12 |
Dsm N.V. |
Production of heterologous proteins in filamentous fungi
|
|
US5741665A
(en)
|
1994-05-10 |
1998-04-21 |
University Of Hawaii |
Light-regulated promoters for production of heterologous proteins in filamentous fungi
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
AUPM823094A0
(en)
|
1994-09-16 |
1994-10-13 |
Goodman Fielder Limited |
Probiotic compositions
|
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
|
RU2078815C1
(ru)
|
1995-01-17 |
1997-05-10 |
Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского |
Штамм бактерий bifidobacterium breve, используемый для получения бактерийных лечебно-профилактических бифидосодержащих препаратов
|
|
JPH08259450A
(ja)
|
1995-03-17 |
1996-10-08 |
Nichinichi Seiyaku Kk |
インターフェロン産生増強剤
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
AUPN698495A0
(en)
|
1995-12-06 |
1996-01-04 |
Pharma Pacific Pty Ltd |
Improved therapeutic formulation and method
|
|
SE508045C2
(sv)
|
1996-02-26 |
1998-08-17 |
Arla Ekonomisk Foerening |
Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
|
|
AUPN881396A0
(en)
|
1996-03-20 |
1996-04-18 |
Arnott's Biscuits Limited |
Enhancement of microbial colonization of the gastrointestinal tract
|
|
EP0901371B1
(en)
|
1996-03-20 |
2008-09-10 |
The University Of New South Wales |
Alteration of microbial populations in the gastrointestinal tract
|
|
DK0894126T3
(da)
|
1996-03-27 |
2006-06-12 |
Novozymes As |
Alkalisk phosphatase-deficient trådformet svamp
|
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
|
SE511524C2
(sv)
|
1997-06-02 |
1999-10-11 |
Essum Ab |
Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
|
|
US5925657A
(en)
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
|
DE19826928A1
(de)
|
1998-06-17 |
1999-12-23 |
Novartis Consumer Health Gmbh |
Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
|
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
ATE252091T1
(de)
|
1999-08-27 |
2003-11-15 |
Lilly Co Eli |
Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren
|
|
CA2395343C
(en)
|
2000-02-08 |
2009-06-30 |
F. Hoffmann-La Roche Ag |
Use of acid-stable proteases in animal feed
|
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
|
ATE325864T1
(de)
*
|
2000-05-25 |
2006-06-15 |
Nestle Sa |
Probiotica für verwendung als haustierfutter
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
AU2002226984A1
(en)
|
2000-11-27 |
2002-06-03 |
Astrazeneca Ab |
Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon
|
|
DE10101793A1
(de)
|
2001-01-17 |
2002-08-01 |
Manfred Nilius |
Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
|
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
|
EP1243273A1
(en)
|
2001-03-22 |
2002-09-25 |
Societe Des Produits Nestle S.A. |
Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
|
|
EP1379552B2
(en)
|
2001-04-20 |
2014-11-19 |
The Institute for Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
EP1260227A1
(en)
|
2001-05-23 |
2002-11-27 |
Societe Des Produits Nestle S.A. |
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
|
|
PE20030284A1
(es)
|
2001-07-26 |
2003-05-01 |
Alimentary Health Ltd |
Cepas de bifidobacterium
|
|
MXPA04001999A
(es)
|
2001-09-05 |
2004-07-16 |
Vsl Pharmaceuticals Inc |
Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
|
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
|
WO2003045317A2
(en)
|
2001-11-27 |
2003-06-05 |
Washington University |
Therapeutic protein and treatments
|
|
CA2476755C
(en)
|
2001-12-17 |
2014-08-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
|
DE10206995B4
(de)
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
|
JP2003261453A
(ja)
|
2002-03-11 |
2003-09-16 |
Nippon Berumu Kk |
Ｅ．フェカリスからなる抗腫瘍剤及び放射線防護剤
|
|
CA2490016C
(en)
|
2002-06-28 |
2017-08-22 |
Puleva Biotech, S.A. |
Probiotic strains, a process for the selection of them, compositions thereof, and their use
|
|
US20040005304A1
(en)
|
2002-07-08 |
2004-01-08 |
Mak Wood, Inc. |
Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
|
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
|
EP1481681A1
(en)
|
2003-05-30 |
2004-12-01 |
Claudio De Simone |
Lactic acid bacteria combination and compositions thereof
|
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
|
WO2005007834A1
(en)
|
2003-07-23 |
2005-01-27 |
Probionic Corp. |
Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
|
|
US7485325B2
(en)
|
2003-08-06 |
2009-02-03 |
Gayle Dorothy Swain |
Animal food supplement compositions and methods of use
|
|
JP4683881B2
(ja)
|
2003-08-27 |
2011-05-18 |
有限会社アーク技研 |
抗腫瘍活性剤
|
|
US8192733B2
(en)
*
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US20050163764A1
(en)
|
2003-09-22 |
2005-07-28 |
Yale University |
Treatment with agonists of toll-like receptors
|
|
GB0323039D0
(en)
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
|
EP2033529B1
(en)
|
2003-10-24 |
2019-12-11 |
N.V. Nutricia |
Synbiotic composition for infants
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
AU2004298384A1
(en)
|
2003-12-17 |
2005-06-30 |
N.V. Nutricia |
Lactic acid producing bacteria and lung function
|
|
ES2235642B2
(es)
|
2003-12-18 |
2006-03-01 |
Gat Formulation Gmbh |
Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
|
|
CA2557800A1
(en)
|
2004-03-22 |
2005-10-06 |
Yossef Raviv |
Cellular and viral inactivation
|
|
EP1755668A2
(en)
|
2004-05-07 |
2007-02-28 |
Hans-Gustaf Ljunggren |
Adjuvants
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
|
WO2005120560A1
(en)
|
2004-06-07 |
2005-12-22 |
Harold David Gunn |
Bacterial compositions for the treatment of cancer
|
|
ES2286558T5
(es)
|
2004-08-24 |
2013-10-15 |
N.V. Nutricia |
Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles
|
|
US20060062742A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for reduction of human malodor
|
|
KR100468522B1
(ko)
|
2004-10-12 |
2005-01-31 |
주식회사 프로바이오닉 |
코로나바이러스와 돼지 써코바이러스 2형의 생육을 억제하는 신규한 내산성 프로바이오틱 엔테로코커스훼시움 프로바이오-63
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
ITMI20042189A1
(it)
|
2004-11-16 |
2005-02-16 |
Anidral Srl |
Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
|
|
BRPI0607743B1
(pt)
|
2005-02-28 |
2020-09-15 |
N. V. Nutricia |
Composição nutricional prebiótica para bebês e uso de uma composição nutricional prebiótica para bebês
|
|
US20090233888A1
(en)
|
2005-03-23 |
2009-09-17 |
Usc Stevens, University Of Southern California |
Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
|
|
EP1861490A4
(en)
|
2005-03-23 |
2010-11-17 |
Univ St Louis |
USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE
|
|
JP2006265212A
(ja)
|
2005-03-25 |
2006-10-05 |
Institute Of Physical & Chemical Research |
Ｉｌ−２１産生誘導剤
|
|
US20100233312A9
(en)
|
2005-04-11 |
2010-09-16 |
The Procter & Gamble Company |
Compositions comprising probiotic and sweetener components
|
|
EP1714660A1
(en)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
Uronic acid and probiotics
|
|
WO2006114778A1
(en)
|
2005-04-26 |
2006-11-02 |
Teagasc- The Agriculture And Food Development Authority |
Probiotic composition suitable for animals
|
|
US7572474B2
(en)
|
2005-06-01 |
2009-08-11 |
Mead Johnson Nutrition Company |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
|
|
US8075934B2
(en)
|
2008-10-24 |
2011-12-13 |
Mead Johnson Nutrition Company |
Nutritional composition with improved digestibility
|
|
JP2007084533A
(ja)
|
2005-08-24 |
2007-04-05 |
Prima Meat Packers Ltd |
免疫応答調節組成物及び該組成物を有効成分とする食品
|
|
US7625704B2
(en)
|
2005-08-31 |
2009-12-01 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for identifying bacteria associated with bacteria vaginosis
|
|
US20080199460A1
(en)
|
2005-09-01 |
2008-08-21 |
Schering Corporation |
Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
|
|
WO2007035057A1
(en)
|
2005-09-23 |
2007-03-29 |
Gwangju Institute Of Science And Technology |
Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients
|
|
US20070280964A1
(en)
*
|
2005-10-06 |
2007-12-06 |
Ruth Knorr |
Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
|
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
|
JP5030960B2
(ja)
|
2005-10-24 |
2012-09-19 |
ネステク ソシエテ アノニム |
食物繊維製剤及び投与方法
|
|
JP2007116991A
(ja)
|
2005-10-28 |
2007-05-17 |
Eternal Light General Institute Inc |
機能性食品
|
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
|
JP2009520689A
(ja)
|
2005-12-01 |
2009-05-28 |
シェーリング コーポレイション |
炎症障害および微生物性疾患を処置するための化合物
|
|
US8889149B2
(en)
|
2006-02-16 |
2014-11-18 |
Wayne State University |
Use of flagellin to prevent and treat gram negative bacterial infection
|
|
US20080260898A1
(en)
|
2006-03-17 |
2008-10-23 |
Marko Stojanovic |
Compositions comprising probiotic and sweetener components
|
|
JP5031249B2
(ja)
|
2006-03-22 |
2012-09-19 |
学校法人北里研究所 |
炎症抑制作用のある菌体含有組成物
|
|
JP2009537547A
(ja)
|
2006-05-18 |
2009-10-29 |
バイオバランス エルエルシー |
生物学的治療組成物およびその使用
|
|
RU2442602C2
(ru)
|
2006-05-26 |
2012-02-20 |
Нестек С.А. |
Питательные композиции на основе экстракта тоути и способы их применения
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
PT2164349E
(pt)
|
2006-08-04 |
2014-12-11 |
Shs Int Ltd |
Fórmula sem proteína
|
|
WO2008031438A2
(en)
|
2006-09-13 |
2008-03-20 |
Region Hovedstaden V/Gentofte Hospital |
Treatment of asthma, eczema and/or allergy using non-pathogenic organisms
|
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
|
CA2667167C
(en)
|
2006-10-27 |
2014-02-18 |
Pfizer Products Inc. |
Hydroxypropyl methyl cellulose hard capsules and process of manufacture
|
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
|
EP1920781B1
(en)
|
2006-11-10 |
2015-03-04 |
Glycotope GmbH |
Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
|
|
WO2008064489A1
(en)
|
2006-12-01 |
2008-06-05 |
Mcmaster University |
Probiotics to inhibit inflammation
|
|
EP2102350A4
(en)
|
2006-12-18 |
2012-08-08 |
Univ St Louis |
INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
JP2008195635A
(ja)
|
2007-02-09 |
2008-08-28 |
Crossfield Bio Inc |
馬用乳酸菌製剤
|
|
BRPI0808052A2
(pt)
|
2007-02-28 |
2014-06-24 |
Mead Johnson Nutrition Co |
Método para tratar ou prevenir inflamação sistêmica.
|
|
PL2134833T3
(pl)
|
2007-03-28 |
2016-09-30 |
|
Probiotyczny szczep Bifidobacterium
|
|
EP2134835B1
(en)
|
2007-03-28 |
2014-10-15 |
Alimentary Health Limited |
Probiotic bifidobacterium strains
|
|
WO2008134450A2
(en)
|
2007-04-24 |
2008-11-06 |
Kemin Industries, Inc. |
Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115
|
|
EP1997499A1
(en)
|
2007-05-31 |
2008-12-03 |
Puleva Biotech, S.A. |
Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
|
|
EP1997906A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Lactobacillus
|
|
EP1997905A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Nucleic acid amplification
|
|
EP1997907A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobacteria
|
|
WO2008153377A1
(en)
|
2007-06-15 |
2008-12-18 |
N.V. Nutricia |
Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
|
|
WO2009000899A1
(en)
|
2007-06-27 |
2008-12-31 |
Laboratorios Ordesa, S.L. |
A novel strain of bifidobacterium and active peptides against rotavirus infections
|
|
HUP0700552A2
(en)
|
2007-08-27 |
2009-03-30 |
Janos Dr Feher |
Method and composition inhibiting inflammation
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
US20100284979A1
(en)
|
2007-10-01 |
2010-11-11 |
University College Cork, National University Of Ireland, Cork |
Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
|
|
EP2203551B1
(en)
|
2007-10-20 |
2013-08-21 |
Université de Liège |
Bifidobacterial species
|
|
ES2473625T3
(es)
|
2007-10-26 |
2014-07-07 |
Brenda E. Moore |
Composición probi�tica y métodos para inducir y mantener la pérdida de peso
|
|
WO2009059284A2
(en)
|
2007-11-02 |
2009-05-07 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
|
EP2065048A1
(en)
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
|
WO2009072889A1
(en)
|
2007-12-07 |
2009-06-11 |
N.V. Nutricia |
Bifidobacterium for dust mite allergy
|
|
US20100330190A1
(en)
|
2007-12-17 |
2010-12-30 |
Compans Richard W |
Immunogenic compositions and methods of use thereof
|
|
ES2343499B1
(es)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
|
AU2009212295A1
(en)
|
2008-02-06 |
2009-08-13 |
The Procter & Gamble Company |
Compositions methods and kits for enhancing immune response to a respiratory condition
|
|
EP2103226A1
(en)
|
2008-03-18 |
2009-09-23 |
Friesland Brands B.V. |
Long-life probiotic food product
|
|
CA2721246A1
(en)
|
2008-04-18 |
2009-10-22 |
Vaxinnate Corporation |
Deletion mutants of flagellin and methods of use
|
|
WO2009138220A1
(en)
|
2008-05-13 |
2009-11-19 |
Glycotope Gmbh |
Fermentation process
|
|
MX2008006546A
(es)
|
2008-05-21 |
2009-11-23 |
Sigma Alimentos Sa De Cv |
Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
CN101590081A
(zh)
|
2008-05-28 |
2009-12-02 |
青岛东海药业有限公司 |
凸腹真杆菌和两形真杆菌制剂及其应用
|
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
EP2133088A3
(en)
|
2008-06-09 |
2010-01-27 |
Nestec S.A. |
Rooibos and inflammation
|
|
WO2009151315A1
(en)
|
2008-06-13 |
2009-12-17 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
|
WO2009154463A2
(en)
|
2008-06-20 |
2009-12-23 |
Stichting Top Institute Food And Nutrition |
Butyrate as a medicament to improve visceral perception in humans
|
|
EP2138186A1
(en)
|
2008-06-24 |
2009-12-30 |
Nestec S.A. |
Probiotics, secretory IgA and inflammation
|
|
WO2010002241A1
(en)
|
2008-06-30 |
2010-01-07 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
|
JP2010034283A
(ja)
|
2008-07-29 |
2010-02-12 |
Hitachi Kokusai Electric Inc |
基板処理装置
|
|
KR101017448B1
(ko)
|
2008-09-18 |
2011-02-23 |
주식회사한국야쿠르트 |
대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품
|
|
US8137718B2
(en)
|
2008-09-19 |
2012-03-20 |
Mead Johnson Nutrition Company |
Probiotic infant products
|
|
US20100074870A1
(en)
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
JP2012510800A
(ja)
|
2008-12-05 |
2012-05-17 |
ネステク ソシエテ アノニム |
低出生体重児において使用するための組成物
|
|
MX2011006701A
(es)
|
2008-12-19 |
2011-07-28 |
Nestec Sa |
Prevencion y tratamiento de diarrea por rotavirus.
|
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
|
KR101579771B1
(ko)
|
2009-03-05 |
2015-12-28 |
애브비 인코포레이티드 |
Ｉｌ-17 결합 단백질
|
|
JP5710876B2
(ja)
|
2009-03-26 |
2015-04-30 |
クロスフィールドバイオ株式会社 |
新規ビフィドバクテリウム属微生物およびその利用
|
|
WO2010129839A1
(en)
|
2009-05-07 |
2010-11-11 |
Tate & Lyle Ingredients France SAS |
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
|
|
MY159273A
(en)
|
2009-05-11 |
2016-12-30 |
Nestec Sa |
Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
|
|
EP2251022A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Non-replicating micro-organisms and their immune boosting effect
|
|
EP2251020A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
|
|
KR20100128168A
(ko)
|
2009-05-27 |
2010-12-07 |
중앙대학교 산학협력단 |
공액 리놀레산 생산능이 우수한 신규한 균주
|
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
WO2010143940A1
(en)
|
2009-06-12 |
2010-12-16 |
N.V. Nutricia |
Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
|
|
WO2010147714A1
(en)
|
2009-06-16 |
2010-12-23 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
CA2768301A1
(en)
|
2009-07-24 |
2011-01-27 |
Southwest Regional Pcr, Llc |
Universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
|
|
US9439449B2
(en)
|
2009-08-18 |
2016-09-13 |
Nestec S.A. |
Nutritional composition comprising Bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
WO2011036539A1
(en)
|
2009-09-23 |
2011-03-31 |
Borody Thomas J |
Therapy for enteric infections
|
|
EP2308498A1
(en)
|
2009-09-30 |
2011-04-13 |
Nestec S.A. |
Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
|
|
WO2011043654A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
EP2485742A4
(en)
|
2009-10-06 |
2013-03-20 |
Scott Dorfner |
ANTIBIOTIC FORMULATIONS WITH REDUCED SIDE EFFECTS ON STOMACH AND DARM
|
|
RU2546251C2
(ru)
|
2009-11-11 |
2015-04-10 |
Алиментари Хелс Лимитед |
Пробиотический штамм бифидобактерий
|
|
JP2013514085A
(ja)
|
2009-12-18 |
2013-04-25 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
プロバイオティックを含むペットフード組成物ならびにそれを調製および使用する方法
|
|
US20150104418A1
(en)
|
2014-12-18 |
2015-04-16 |
Microbios, Inc. |
Bacterial composition
|
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
|
NL2004200C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides in weight management.
|
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
JP5737646B2
(ja)
|
2010-03-24 |
2015-06-17 |
森下仁丹株式会社 |
抗アレルギー剤
|
|
WO2011121379A1
(en)
|
2010-03-30 |
2011-10-06 |
Assistance Publique - Hopitaux De Paris |
Use of bifidobacteria for preventing allergy in breastfed infants
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011149335A1
(en)
|
2010-05-25 |
2011-12-01 |
N.V. Nutricia |
Immune imprinting nutritional composition
|
|
US20130195802A1
(en)
|
2010-06-01 |
2013-08-01 |
Moore Research Enterprises Llc |
Cellular Constituents From Bacteroides, Compositions Thereof, and Therapeutic Methods Employing Bacteroides or Cellular Constituents Thereof
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
TWI417054B
(zh)
|
2010-06-15 |
2013-12-01 |
Jen Shine Biotechnology Co Ltd |
新穎糞腸球菌ｌｊｓ－０１及其益生用途
|
|
EP2397145A1
(en)
|
2010-06-18 |
2011-12-21 |
Nestec S.A. |
L. johnsonii La1, B. longum NCC2705 and immune disorders
|
|
FR2962045B1
(fr)
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
|
TWI401086B
(zh)
|
2010-07-20 |
2013-07-11 |
Univ China Medical |
胚芽乳酸桿菌及其用途
|
|
SG187201A1
(en)
|
2010-07-26 |
2013-02-28 |
Qu Biolog Inc |
Immunogenic anti-inflammatory compositions
|
|
CN103124559B
(zh)
|
2010-08-04 |
2017-03-29 |
托马斯·朱利叶斯·波洛迪 |
用于粪便菌群植入的组合物及其制备和使用方法以及递送该组合物的装置
|
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
KR101250463B1
(ko)
|
2010-10-12 |
2013-04-15 |
대한민국 |
신생아 분변에서 분리한 내산소성 비피도박테리움 롱검 비피더스 유산균 및 이를 이용한 프로바이오틱 조성물
|
|
EP2633074A1
(en)
|
2010-10-27 |
2013-09-04 |
Quantibact A/s |
Capture of target dna and rna by probes comprising intercalator molecules
|
|
CN102031235B
(zh)
|
2010-11-09 |
2012-07-25 |
中国农业大学 |
一种粪肠球菌anse228及其应用
|
|
EP2455092A1
(en)
|
2010-11-11 |
2012-05-23 |
Nestec S.A. |
Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
|
|
US20120128644A1
(en)
|
2010-11-24 |
2012-05-24 |
Oragenics, Inc. |
Use of Bacteria to Treat and Prevent Respiratory Infections
|
|
CN102093967B
(zh)
|
2010-12-02 |
2013-01-30 |
中国农业科学院特产研究所 |
一株水貂源屎肠球菌及其应用
|
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
EP2663367A4
(en)
|
2011-01-10 |
2014-08-06 |
Cleveland Biolabs Inc |
USE OF A TOLL-TYPE RECEPTOR AGONIST FOR THE TREATMENT OF CANCER
|
|
PL2481299T3
(pl)
|
2011-01-31 |
2017-09-29 |
Synformulas Gmbh |
Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
|
|
JP5840368B2
(ja)
|
2011-02-02 |
2016-01-06 |
カルピス株式会社 |
関節炎予防改善用物質
|
|
WO2012108830A1
(en)
|
2011-02-09 |
2012-08-16 |
Lavivo Ab |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
|
AU2012225305B2
(en)
|
2011-03-09 |
2017-06-08 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
|
WO2012140636A1
(en)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
JP2014512388A
(ja)
|
2011-04-20 |
2014-05-22 |
マイコ・バイオ，インコーポレーテッド |
免疫反応を増進するための組成物および方法
|
|
EP2707379A4
(en)
|
2011-05-13 |
2014-10-08 |
Glycosyn LLC |
USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
|
|
KR20120133133A
(ko)
|
2011-05-30 |
2012-12-10 |
한국 한의학 연구원 |
생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
|
|
WO2012170478A2
(en)
|
2011-06-06 |
2012-12-13 |
The University Of North Carolina At Chapel Hill |
Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
|
|
GB201110095D0
(en)
|
2011-06-15 |
2011-07-27 |
Danisco |
Method of treatment
|
|
JP2013005759A
(ja)
|
2011-06-24 |
2013-01-10 |
Kyodo Milk Industry Co Ltd |
マウス腸内菌叢の推測方法
|
|
JP6222626B2
(ja)
|
2011-07-07 |
2017-11-01 |
長岡香料株式会社 |
フルクトース吸収阻害剤
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
CN102304483A
(zh)
|
2011-08-12 |
2012-01-04 |
北京金泰得生物科技股份有限公司 |
一株饲用屎肠球菌及其应用
|
|
KR101261872B1
(ko)
|
2011-08-23 |
2013-05-14 |
대한민국 (식품의약품안전처장) |
장내 미생물 효소복합체 및 이의 제조방법
|
|
CA2848762C
(en)
|
2011-09-14 |
2021-07-27 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
ES2582284T3
(es)
|
2011-10-11 |
2016-09-12 |
Achim Biotherapeutics Ab |
Composición que comprende microbiota intestinal humana anaeróbicamente cultivada
|
|
CN103082292B
(zh)
|
2011-11-02 |
2015-03-04 |
深圳华大基因研究院 |
罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
|
|
CN102373172B
(zh)
|
2011-11-03 |
2013-03-20 |
北京龙科方舟生物工程技术有限公司 |
一株屎肠球菌及其应用
|
|
WO2013080561A1
(en)
|
2011-12-01 |
2013-06-06 |
University Of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
ES2408279B1
(es)
|
2011-12-15 |
2014-09-09 |
Universidad De Las Palmas De Gran Canaria |
Bacteria acido láctica probiótica
|
|
ITBG20120010A1
(it)
|
2012-02-24 |
2013-08-25 |
Milano Politecnico |
Dispositivo per l'addestramento chirurgico
|
|
ITMI20120471A1
(it)
|
2012-03-26 |
2013-09-27 |
Giovanni Mogna |
Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
|
|
JP5792105B2
(ja)
|
2012-03-27 |
2015-10-07 |
森永乳業株式会社 |
ラクト−ｎ−ビオースｉの製造方法
|
|
EP2832859B1
(en)
|
2012-03-30 |
2018-07-25 |
Ajinomoto Co., Inc. |
Diabetes-inducible bacterium
|
|
WO2013154826A2
(en)
|
2012-04-11 |
2013-10-17 |
Nestec Sa |
Methods for diagnosing impending diarrhea
|
|
GB201206599D0
(en)
|
2012-04-13 |
2012-05-30 |
Univ Manchester |
Probiotic bacteria
|
|
JP2015512936A
(ja)
|
2012-04-13 |
2015-04-30 |
トラスティーズ オブ ボストン カレッジ |
プレバイオティクス組成物およびその使用方法
|
|
DK2850202T3
(da)
|
2012-05-18 |
2020-05-18 |
Genome Res Ltd |
Fremgangsmåder og grupper
|
|
ES2436251B1
(es)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
|
|
NZ703394A
(en)
|
2012-06-04 |
2017-01-27 |
Centre For Digestive Diseases |
Compositions and methods for treating crohn’s disease and related conditions and infections
|
|
CN102743420A
(zh)
|
2012-06-06 |
2012-10-24 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
WO2014001368A1
(en)
|
2012-06-25 |
2014-01-03 |
Orega Biotech |
Il-17 antagonist antibodies
|
|
ES2609654T3
(es)
|
2012-07-31 |
2017-04-21 |
Nestec S.A. |
Composición nutritiva para promover la salud del aparato locomotor de pacientes que sufren la enfermedad del intestino inflamatorio (IBD)
|
|
US20150211053A1
(en)
|
2012-08-01 |
2015-07-30 |
Bgi-Shenzhen |
Biomarkers for diabetes and usages thereof
|
|
RU2015111258A
(ru)
|
2012-08-29 |
2016-10-20 |
Саликс Фармасьютикалз, ИНК. |
Слабительные композиции и способы лечения запора и связанных с ним желудочно-кишечных заболеваний и состояний
|
|
AU2013308826B2
(en)
|
2012-08-29 |
2019-04-18 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
|
US9994809B2
(en)
|
2012-09-13 |
2018-06-12 |
Massachusetts Institute Of Technology |
Programmable drug delivery profiles of tumor-targeted bacteria
|
|
KR101473058B1
(ko)
|
2012-09-19 |
2014-12-16 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
|
CN103652322B
(zh)
|
2012-09-21 |
2016-02-10 |
临沂思科生物科技有限公司 |
一种含乳酸菌的复合益生菌饲料添加剂的制备方法
|
|
WO2014053608A1
(en)
|
2012-10-03 |
2014-04-10 |
Metabogen Ab |
Identification of a person having risk for atherosclerosis and associated diseases by the person's gut microbiome and the prevention of such diseases
|
|
FR2997091B1
(fr)
|
2012-10-22 |
2016-05-06 |
Fond Mediterranee Infection |
Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene
|
|
US9839657B2
(en)
|
2012-10-30 |
2017-12-12 |
Deerland Enzymes, Inc. |
Prebiotic compositions comprising one or more types of bacteriophage
|
|
CN104755092A
(zh)
|
2012-10-30 |
2015-07-01 |
雀巢产品技术援助有限公司 |
用于递送协同免疫作用的包含微粒和益生菌的组合物
|
|
WO2014070014A1
(en)
|
2012-11-01 |
2014-05-08 |
Rijksuniversiteit Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
|
WO2014075745A1
(en)
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
|
NZ709392A
(en)
|
2012-11-23 |
2016-10-28 |
Seres Therapeutics Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
JP2016501852A
(ja)
|
2012-11-26 |
2016-01-21 |
トーマス・ジュリアス・ボロディ |
糞便微生物叢の回復のための組成物、ならびにそれらを作製および使用する方法
|
|
PL2898075T3
(pl)
|
2012-12-12 |
2016-09-30 |
|
PROJEKTOWANIE i OPTYMALIZACJA ULEPSZONYCH SYSTEMÓW, SPOSOBY I KOMPOZYCJE ENZYMÓW DO MANIPULACJI SEKWENCJĄ
|
|
JP2016501531A
(ja)
|
2012-12-12 |
2016-01-21 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
配列操作および治療適用のための系、方法および組成物の送達、エンジニアリングおよび最適化
|
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
|
US20140193464A1
(en)
|
2013-01-08 |
2014-07-10 |
Imagilin Technology, Llc |
Effects of probiotics on humans and animals under environmental or biological changes
|
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
|
RU2664479C2
(ru)
|
2013-02-04 |
2018-08-17 |
Серес Терапеутикс, Инк. |
Композиции и способы
|
|
AU2014219048B2
(en)
|
2013-02-22 |
2018-12-13 |
The Regents Of The University Of California |
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
|
|
US20160000838A1
(en)
|
2013-03-05 |
2016-01-07 |
Rijksuniversiteit Groningen |
Use of Faecalibacterium Prausnitzii Htf-f (DSM 26943) to Suppress Inflammation
|
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
|
CA2904389C
(en)
|
2013-03-14 |
2018-09-18 |
Jerome J. Schentag |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
|
CN103156888A
(zh)
|
2013-03-18 |
2013-06-19 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用
|
|
CN103142656A
(zh)
|
2013-03-18 |
2013-06-12 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备防治结肠癌组合物中的应用
|
|
CN103146620A
(zh)
|
2013-03-25 |
2013-06-12 |
广州知光生物科技有限公司 |
具有益生菌特性的脆弱拟杆菌
|
|
JP2014196260A
(ja)
|
2013-03-29 |
2014-10-16 |
公立大学法人奈良県立医科大学 |
慢性閉塞性肺疾患の予防又は治療用組成物
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
EP2994161B1
(en)
|
2013-05-10 |
2020-10-28 |
California Institute of Technology |
Probiotic prevention and treatment of colon cancer
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
CA2914636C
(en)
|
2013-06-05 |
2021-04-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
|
WO2014201037A2
(en)
|
2013-06-10 |
2014-12-18 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
|
WO2014200334A1
(en)
|
2013-06-14 |
2014-12-18 |
N.V. Nutricia |
Synbiotic composition for treatment of infections in allergic patients
|
|
WO2015003001A1
(en)
|
2013-07-01 |
2015-01-08 |
The Washington University |
Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom
|
|
WO2015003305A1
(zh)
|
2013-07-08 |
2015-01-15 |
吉瑞高新科技股份有限公司 |
电子烟盒
|
|
EP3019181A4
(en)
|
2013-07-09 |
2016-09-21 |
Puretech Ventures Llc |
COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MICROFLORE DERIVED MOLECULES FOR THE TREATMENT OF DISEASE
|
|
WO2015013214A2
(en)
|
2013-07-21 |
2015-01-29 |
Whole Biome, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
|
EP3027058B1
(en)
|
2013-07-31 |
2020-07-15 |
Incredible Foods, Inc. |
Encapsulated functional food compositions
|
|
WO2015021936A1
(en)
|
2013-08-16 |
2015-02-19 |
The University Of Hong Kong |
Method and compositions for treating cancer using probiotics cross-reference to related application
|
|
CN103509741B
(zh)
|
2013-08-22 |
2015-02-18 |
河北农业大学 |
布劳特菌auh-jld56及其在牛蒡苷元转化中的应用
|
|
WO2015038731A1
(en)
|
2013-09-12 |
2015-03-19 |
The Johns Hopkins University |
Biofilm formation to define risk for colon cancer
|
|
PL3071052T3
(pl)
|
2013-10-18 |
2020-07-27 |
Innovachildfood Ab |
Zbilansowany pod względem odżywczym złożony posiłek dla niemowląt i małych dzieci oraz sposób otrzymywania wspomnianego posiłku
|
|
PL229020B1
(pl)
|
2013-11-13 |
2018-05-30 |
Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna |
Nowy szczep Bifidobacterium breve
|
|
CN116370507A
(zh)
|
2013-11-25 |
2023-07-04 |
赛里斯治疗公司 |
协同细菌组合物以及其制造方法和用途
|
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
CN103981115B
(zh)
*
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其应用
|
|
CN103981117B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其培养方法和应用
|
|
CN103820363B
(zh)
|
2014-01-27 |
2016-02-24 |
福建省农业科学院生物技术研究所 |
一种屎肠球菌菌粉的制备与应用
|
|
CN103865846B
(zh)
|
2014-02-27 |
2016-03-30 |
扬州绿保生物科技有限公司 |
一种屎肠球菌及其制备方法
|
|
CN103849590B
(zh)
|
2014-03-25 |
2016-07-06 |
上海交通大学 |
一株耐酸短双歧杆菌BB8dpH及其应用
|
|
KR101683474B1
(ko)
|
2014-03-26 |
2016-12-08 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
|
US9783858B2
(en)
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
|
KR101583546B1
(ko)
|
2014-04-09 |
2016-01-11 |
국립암센터 |
유전자 다형성을 이용한 소라페닙 치료에 대한 반응성 예측방법
|
|
MX2016013247A
(es)
|
2014-04-10 |
2017-05-03 |
Riken |
Composiciones y metodos para induccion de celulas th17.
|
|
CN104195075B
(zh)
|
2014-08-14 |
2017-04-19 |
生合生物科技股份有限公司 |
一种屎肠球菌ef08及包含它的饲料添加物和饲料
|
|
WO2015168534A1
(en)
|
2014-05-02 |
2015-11-05 |
Novogy, Inc. |
Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
|
|
CN106572968A
(zh)
|
2014-05-08 |
2017-04-19 |
帕诺泰斯制药有限公司 |
用于治疗眼科疾病和障碍的化合物
|
|
WO2016019506A1
(en)
|
2014-08-05 |
2016-02-11 |
BGI Shenzhen Co.,Limited |
Use of eubacterium in the prevention and treatment for colorectal cancer related diseases
|
|
US10925953B2
(en)
|
2014-08-28 |
2021-02-23 |
Yale University |
Compositions and methods for treating an inflammatory disease or disorder
|
|
US20160058808A1
(en)
|
2014-09-03 |
2016-03-03 |
California Institute Of Technology |
Microbe-based modulation of serotonin biosynthesis
|
|
CN104546933A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
粪拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546940A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
平常拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546935A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546934B
(zh)
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546932A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
卵形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546942A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多氏拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
WO2016057671A1
(en)
|
2014-10-07 |
2016-04-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
|
CN114376234A
(zh)
|
2014-10-24 |
2022-04-22 |
进化生物系统股份有限公司 |
活化的双歧杆菌及其应用方法
|
|
JP6800846B2
(ja)
|
2014-10-30 |
2020-12-16 |
カリフォルニア インスティチュート オブ テクノロジー |
神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
|
|
EP3212207A4
(en)
|
2014-10-30 |
2018-06-13 |
California Institute of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
CN104435000A
(zh)
|
2014-11-12 |
2015-03-25 |
江南大学 |
乳酸菌对支气管哮喘治疗中的应用
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
EP3223835B1
(en)
|
2014-11-25 |
2024-11-13 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
EA202090948A1
(ru)
|
2014-12-23 |
2020-11-30 |
4Д Фарма Рисерч Лимитед |
Иммуномодуляция
|
|
PT3193901T
(pt)
|
2014-12-23 |
2018-06-29 |
4D Pharma Res Ltd |
Polipéptido de pirina e modulação imunitária
|
|
CN104560820B
(zh)
|
2014-12-30 |
2017-10-20 |
杭州师范大学 |
屎肠球菌kq2.6及应用
|
|
AU2016209244A1
(en)
|
2015-01-23 |
2017-08-17 |
Helena M.G.P.V. Reis |
Use of short chain fatty acids in cancer prevention
|
|
CN105982919A
(zh)
|
2015-02-26 |
2016-10-05 |
王汉成 |
生物减速剂抗癌技术
|
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
WO2016149449A1
(en)
|
2015-03-18 |
2016-09-22 |
Tufts University |
Compositions and methods for preventing colorectal cancer
|
|
EP3270938A4
(en)
|
2015-03-18 |
2018-12-19 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
|
MX2017015473A
(es)
|
2015-06-01 |
2018-08-15 |
Univ Chicago |
Tratamiento contra el cancer por manipulacion de la microflora comensal.
|
|
ES2748812T3
(es)
|
2015-06-15 |
2020-03-18 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
ME03595B
(me)
|
2015-06-15 |
2020-07-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
SG10201912323VA
(en)
|
2015-06-15 |
2020-02-27 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
CN105112333A
(zh)
|
2015-08-31 |
2015-12-02 |
江南大学 |
一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
|
|
GB201520497D0
(en)
*
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
LT3209310T
(lt)
|
2015-11-20 |
2018-04-25 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterinius kamienus
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
EP3379935A4
(en)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
METHOD AND COMPOSITIONS FOR REDUCING VANCOMYCIN RESISTANT ENTEROKOKKEN
|
|
BR112018067689A2
(pt)
|
2016-03-04 |
2019-01-08 |
4D Pharma Plc |
composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商４Ｄ製藥有限公司 |
包含細菌菌株之組合物
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
WO2018112363A1
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating cancer using parabacteroides
|
|
WO2018112365A2
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
|